Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | APEX1 | P27695 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27675295 | 0.93 | GAA (0.52) | GAACTBP2POLBTDP1APEX1 | |
| SCHEMBL28221360 | 0.93 | GAA (0.52) | GAACTBP2POLBTDP1APEX1 | |
| SCHEMBL28191412 | 0.91 | ALDH1A1 (0.62) | GAACTBP2TDP1SMN1; SMN2ALDH1A1 | |
| SCHEMBL5163933 | 0.88 | GAA (0.52) | GAACTBP2POLBTDP1APEX1 | |
| SCHEMBL823410 | 0.86 | GAA (0.50) | GAACTBP2POLBTDP1APEX1 | |
| SCHEMBL7256741 | 0.86 | TDP1 (0.55) | GAACTBP2POLBTDP1APEX1 | |
| SCHEMBL756910 | 0.86 | PTPN1 (0.52) | GAACTBP2POLBTDP1APEX1 | |
| SCHEMBL14609496 | 0.86 | GAA (0.50) | GAACTBP2POLBTDP1APEX1 | |
| SCHEMBL1151049 | 0.86 | GAA (0.50) | GAACTBP2POLBTDP1APEX1 | |
| SCHEMBL12206806 | 0.86 | TDP1 (0.50) | GAACTBP2POLBTDP1APEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117486681-A | Preparation method of 3-aryl/alkyl-beta-anisole compound | 中国海洋石油集团有限公司 | 2024-02-02 | — | — | CN | disclosed |
| CN-117486682-A | Preparation method of functionalized beta-naphthalenyl ether compound | 中国海洋石油集团有限公司 | 2024-02-02 | — | — | CN | disclosed |
| US-11370733-B2 | Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object | CANON KABUSHIKI KAISHA (JP) | 2022-06-28 | — | — | US | disclosed |
| US-20220081378-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2022-03-17 | — | — | US | disclosed |
| US-20200048171-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT | CANON KABUSHIKI KAISHA (JP) | 2020-02-13 | — | — | US | disclosed |
| EP-3608303-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT | CANON KABUSHIKI KAISHA (JP) | 2020-02-12 | — | — | EP | disclosed |
| EP-2598484-B1 | PROCESS FOR THE PREPARATION OF KEY INTERMEDIATES FOR THE SYNTHESIS OF STATINS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | LEK PHARMACEUTICALS (SI) | 2016-06-29 | — | — | EP | disclosed |
| US-9085538-B2 | Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof | LEK PHARMACEUTICALS D.D. (SI) | 2015-07-21 | — | — | US | disclosed |
| US-20150126502-A1 | INHIBITORS OF POLO-LIKE KINASE | ELAN PHARM INC (US) | 2015-05-07 | — | — | US | disclosed |
| EP-2516441-B1 | PTERIDINONES AS INHIBITORS OF POLO-LIKE KINASE | ELAN PHARM INC (US) | 2015-01-21 | — | — | EP | disclosed |
| US-20020103400-A1 | Process for producing optically active 1-(fluoro- or trifluoromethyl-substituted phenyl) ethylamine and process for purifying same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2002-08-01 | — | — | US | disclosed |
| EP-0889920-B1 | POLYPHENYLENE OLIGOMERS AND POLYMERS | DOW CHEMICAL CO (US) | 2002-02-13 | — | — | EP | disclosed |
| US-6288188-B1 | ACETYLENIC POLYMERS; INTEGRATED CIRCUITS, DIELECTRICS, MICROELECTRONICS | THE DOW CHEMICAL COMPANY | 2001-09-11 | — | — | US | disclosed |
| EP-1121359-A1 | IMIDAZO-ISOQUINOLINE COMPOUNDS, THEIR COMPOSITIONS AND USES | THE PROCTER & GAMBLE COMPANY (US) | 2001-08-08 | — | — | EP | disclosed |
| US-6159985-A | Imidazo-isoquinoline compounds, their compositions and uses | THE PROCTER & GAMBLE COMPANY (US) | 2000-12-12 | — | — | US | disclosed |
| WO-2000021961-A1 | IMIDAZO-ISOQUINOLINE COMPOUNDS, THEIR COMPOSITIONS AND USES | THE PROCTER & GAMBLE COMPANY (US) | 2000-04-20 | — | — | WO | disclosed |
| EP-0980872-A2 | Catalysts based upon fulvene-metal complexes | Bayer Aktiengesellschaft (DE) | 2000-02-23 | — | — | EP | disclosed |
| US-5965679-A | BASED A BISCYCLOPENTADIENONE AND AN AROMATIC DIACETYLENE; CURING; LOW DIELECTRIC; INTEGRATED CIRCUITS; MICROELECTRONICS; PRINTED CIRCUITS | THE DOW CHEMICAL COMPANY (US) | 1999-10-12 | — | — | US | disclosed |
| CN-1013671-B | PREPARATION METHOD FOR PYRAZOLINES | SCHERING AG (DE) | 1991-08-28 | — | — | CN | disclosed |
| CN-86108628-A | Preparation method for pyrazolines | — | 1987-07-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048171-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT | OCIAD1, L1CAM, SPIN4 | GAA 3284/4885CTBP2 3673/4885POLB 4314/4885 |
| US-20150126502-A1 | INHIBITORS OF POLO-LIKE KINASE | POLK, PLK1, POLR2E | GAA 712/4885CTBP2 4702/4885POLB 9/4885 |
| US-20020103400-A1 | Process for producing optically active 1-(fluoro- or trifluoromethyl-substituted phenyl) ethylamine and process for purifying same | MAP2K5, MAP2K4, MAP2K1 | GAA 1236/4885CTBP2 4715/4885POLB 789/4885 |
| US-11370733-B2 | Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object | OCIAD1, L1CAM, SPIN4 | GAA 3284/4885CTBP2 3673/4885POLB 4314/4885 |
| US-20220081378-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CCNL2, ORC3, OR51E2 | GAA 3990/4885CTBP2 1972/4885POLB 2651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.